CMS
60
2
BRK.B
42
2
EQIX
62
2
MTB
65
2
BIIB
28
2
VRSN
57
4
GS
73
7
ZTS
49
2
CINF
51
4
AMZN
55
-3
A
41
5
MDLZ
36
2
MTCH
42
5
F
47
4
UA
59
14
GILD
49
2
AZO
48
2
PH
73
3
CMG
67
3
MAS
56
5
CMS
60
2
BRK.B
42
2
EQIX
62
2
MTB
65
2
BIIB
28
2
VRSN
57
4
GS
73
7
ZTS
49
2
CINF
51
4
AMZN
55
-3
A
41
5
MDLZ
36
2
MTCH
42
5
F
47
4
UA
59
14
GILD
49
2
AZO
48
2
PH
73
3
CMG
67
3
MAS
56
5
Financhill
Back

Entrada Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%
Sell
30

SRPT
Sarepta Therapeutics

Last Price:
114.28
Seasonality Move:
16.38%
Buy
58
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $110.50. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $110.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 50.91 Buy
Chaikin Money Flow: 10625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.89 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 63193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.48 Sell
20-day SMA: 18.27 Sell
50-day SMA: 16.93 Buy
200-day SMA: 15.19 Buy
8-day EMA: 18.24 Sell
20-day EMA: 18.15 Sell
50-day EMA: 17.37 Buy
200-day EMA: 15.84 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.88 Sell
50-day SMA: 122.22 Sell
200-day SMA: 130.09 Sell
8-day EMA: 110.76 Sell
20-day EMA: 116.02 Sell
50-day EMA: 122.15 Sell
200-day EMA: 126.16 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):